Guangzhou Virotech Pharmaceutical Co., Ltd.
PrivateLast Round
Strategic
Nov 23, 2022
Est. Valuation
$134.27M
Total Funding Raised
$13.99M
Company Overview
Guangzhou Virotech Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Strategic round in November 2022.
Guangzhou Virotech Pharmaceutical Co., Ltd. is a biotechnology company that develops innovative oncolytic virus therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Virotech Pharmaceutical Co., Ltd. Comparables
Compare Guangzhou Virotech Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou ConVerd Co., Ltd. | 88% | |
| Wuhan Binhui Biopharmaceutical Co., Ltd. | 87% | |
| ImmVira | 86% |
For institutional investors. Book with your work email.
Guangzhou Virotech Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 23, 2022 | ||||
| Series C | Feb 1, 2021 |
For institutional investors. Book with your work email.
Guangzhou Virotech Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guangzhou Industrial Investment Holding Group | Series C |
| Huangpu Biomedical Industry Investment Fund | Series C |
| Guangdong Technology Financial Group | Series C |
| 中科科创文化集团有限公司 | Series C |
| 湾区资管 | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 23, 2022
$14M round led by Boai NKY Medical Holdings Ltd.
- Feb 1, 2021
Raised Series C round with multiple investors including Guangzhou Industrial Investment Holding Group.
For institutional investors. Book with your work email.
Guangzhou Virotech Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guangzhou Virotech Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Virotech Pharmaceutical Co., Ltd. a public or private company?
Guangzhou Virotech Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Guangzhou Virotech Pharmaceutical Co., Ltd.?
Guangzhou Virotech Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Guangzhou Virotech Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guangzhou Virotech Pharmaceutical Co., Ltd. worth (valuation)?
Guangzhou Virotech Pharmaceutical Co., Ltd.'s valuation is estimated at $134.3M based on funding round data.
Can I buy Guangzhou Virotech Pharmaceutical Co., Ltd. stock?
Guangzhou Virotech Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guangzhou Virotech Pharmaceutical Co., Ltd.'s last funding round?
Guangzhou Virotech Pharmaceutical Co., Ltd.'s most recent funding round was Strategic on November 23, 2022.
Who are the main investors in Guangzhou Virotech Pharmaceutical Co., Ltd.?
Key investors in Guangzhou Virotech Pharmaceutical Co., Ltd. include Guangzhou Industrial Investment Holding Group, Huangpu Biomedical Industry Investment Fund, Guangdong Technology Financial Group, 中科科创文化集团有限公司, 湾区资管.
Will Guangzhou Virotech Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Virotech Pharmaceutical Co., Ltd..
How can I track Guangzhou Virotech Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Guangzhou Virotech Pharmaceutical Co., Ltd.'s shares on secondary markets.